| Notice Filed with SOS |
04/20/2020 |
| Rule |
ProposedRuleAttach2020-00258.pdf |
| Additional Information |
AddInfoAttach2020-00258.pdf |
| Statutory Authority |
Sections 25-4-1004(1)(c)(I-IV) and 25-4-1004.5(3)(b)(V), C.R.S with consideration of 25-4-1003(2)(a). |
| Description of Subjects/Issues |
The proposed revisions add Hemoglobinopathies (Hgb) the list of conditions with exceptions so that the second newborn screening for Hgb would only occur on a subset of specimens meeting certain criteria, rather than routinely on all specimens. |
| Purpose/Objective of Rule |
The proposed revisions add Hemoglobinopathies (Hgb) the list of conditions with
exceptions so that the second newborn screening for Hgb would only occur on a
subset of specimens meeting certain criteria, rather than routinely on all
specimens. |
| Basis And Purpose |
BasisAndPurposeAttachment2020-00258.doc
|
| Regulatory analysis |
RegulatoryAnalysisAttachment2020-00258.doc
|
| Comments |
Note Added 05/04/2020: This rulemaking hearing will be held via Zoom. Zoom link:
https://us02web.zoom.us/meeting/register/tZErfu2hpjMjG9NMl0EooJ9cVgk2j_EDnNX1 |
| Submitted in response to issues raised by COLS/OLLS? |
No
|
| Is this rule adopted in response to recent legislation? |
No
|
| Hearing Date |
06/17/2020 |
| Hearing Time |
10:00 AM |
| Hearing Location |
Sabin-Cleere Conference Room, 4300 Cherry Creek S. Drive, Denver, CO 80246 |
| Contact Name |
Emily Travanty |
| Contact Title |
Scientific Director |
| Contact Telephone |
303-692-3094 |
| Contact email |
emily.travanty@state.co.us |